Stocks
Teva Pharmaceutical Industries (TEVA) Debt/EBITDA US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| Debt/EBITDA | 7.90 | 5.25 | 4.70 | 4.57 | 3.97 | 4.06 | |||
| Changes by years, y/y, % | -8% | -33% | -10% | -3% | -13% | -14.3% | |||
Teva Pharmaceutical Industries. Debt/EBITDA
Teva Pharmaceutical Industries. Debt/EBITDA, changes, %
Teva Pharmaceutical Industries (TEVA) Debt/EBITDA US GAAP (quarter values) |
||||||||
| 2023Q2 | 2023Q3 | 2023Q4 | 2023Q4 | 2024Q1 | LTM ? | |||
| Debt/EBITDA | 4.79 | 4.64 | 4.71 | 3.95 | 3.85 | 4.06 | ||
| Changes by years, y/y, % | -4% | -1% | +3% | -14% | -20% | |||
| Changes by quarters, q/q, % | -1% | -3% | +1% | -16% | -2% | |||
